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Abstract
The protective immunity of natural killer (NK) cells against malarial infections is thought to be due to early production of
type II interferon (IFN) and possibly direct NK cell cytotoxicity. To better understand this mechanism, a microarray analysis
was conducted on NK cells from healthy donors PBMCs that were co-cultured with P. falciparum 3D7-infected erythrocytes.
A very similar pattern of gene expression was observed among all donors for each treatment in three replicas. Parasites
particularly modulated genes involved in IFN-a/b signaling as well as molecules involved in the activation of interferon
regulatory factors, pathways known to play a role in the antimicrobial immune response. This pattern of transcription was
entirely different from that shown by NK cells treated with IL-12 and IL-18, in which IFN-c- and TREM-1-related genes were
over-expressed. These results suggest that P. falciparum parasites and the cytokines IL-12 and IL-18 have diverse imprints on
the transcriptome of human primary NK cells. IFN-a-related genes are the prominent molecules induced by parasites on NK
cells and arise as candidate biomarkers that merit to be further investigated as potential new tools in malaria control.
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Introduction
Infections caused by malaria parasites, especially by the species
Plasmodium falciparum, remain a serious world health concern. The
innate and adaptive arms of the immune system are involved in
immunity to malaria, however, the engaged macrophages,
dendritic cells, cd T cells, natural killer (NK) cells, and NKT
cells fail to fully eliminate the infection [1,2].
Characterized by cytotoxicity and cytokine secretion, NK cells
play a critical role as the front line of defence against pathogens
and tumor cells. Within the setting of malaria, several studies
have elucidated the interactions between NK cells, infected
erythrocytes (iRBCs) and other immune cells leading to specific
NK responses to P. falciparum [3–5]. Experiments performed with
NK cells derived from malaria-naive or infected individuals
showed that these cells have cytolytic activity against P. falciparum-
iRBCs that is possibly mediated by FAS and Granzyme B [6,7].
The DBL-alpha domain of P. falciparum-infected erythrocyte
membrane protein 1 (PFEMP1) was identified as the molecule
through which NK cells recognize iRBCs [8]. MYD88-associated
IL18R in NK cells was shown to be the major indirect sensor for
P. falciparum infection [9].
Experimental evidence suggested that, in addition to their up-
regulation of CD69 and CD25 after contact with iRBCs, NK are
one of the first cells to produce IFN-c in response to P. falciparum
infection [3,5]. This event was described to be dependent on cross-
talk with accessory cells either via direct or indirect interactions.
The possible bidirectional interplay between ICAM and LFA-1 on
NK cells and macrophages was shown to be important for NK cell
up-regulation of CD69 and IFN-c secretion [10]. Indirectly, the
production of cytokines by accessory cells, especially IL-12, IL-18,
IFN-alpha and IL-2, was shown to boost NK cell activation and
IFN-c release in response to iRBCs [11].
However, the magnitude of IFN-c release by NK cells is known
to be heterogeneous among individuals, possibly influencing
susceptibility to disease [5]. In this line, qualitative and
quantitative differences in NK subsets found in malaria patients
were linked to the severity of the disease [3]. In addition,
correlations between KIR genotype and NK cell responsiveness to
iRBCs have been reported [4].
Microarray techniques have been widely used for research as
well as for diagnostic purposes. Therefore, applications pertinent
to host-microorganism interactions may be a good predictor of the
biological processes thereby involved. In this study, Affymetrix
oligonucleotide microarrays were used to examine the gene
expression profile of primary NK cells from three healthy donors
that were co-cultured with P. falciparum parasites. This pattern of
gene expression was compared to the same NK cells following
stimulation with IL-12+IL-18.
The response of NK cells to malaria has been the topic of
several studies over the previous few years, but there is still a lack
of information regarding the impact of P. falciparum on NK cells at
a transcriptional level. A greater understanding of the NK cell
mechanisms of sensing and responding to iRBCs is needed seeking
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24963the advantages of NK cell-targeted vaccines development against
malaria.
Materials and Methods
Ethics statement
The three healthy individuals who served as NK cell donors are
themselves authors of this study. Therefore, acquisition of verbal
informed consent was considered sufficient by the ethics
committee for the study approval. Verbal consent was obtained
in the presence of a witness unrelated to the study, who has
attested to its voluntary character in a signed document. The study
was approved by the Ethics Committee of the University of
Tu ¨bingen, Germany.
P. falciparum culture
The P. falciparum laboratory strain 3D7 was maintained in
continuous culture as described elsewhere [12] and frequently
tested for mycoplasma contamination by PCR prior to co-
cultivation with NK cells. Parasites were constantly synchronized
with 5% sorbitol. Mature schizont-iRBCs were harvested by
magnetic cell sorting with LD columns (MACS; Miltenyi Biotec,
Berg. Gladbach, Germany). Schizonts’ purity (.90%) and red
blood cell integrity were confirmed by Giemsa stain.
PBMCs preparation
Venous blood was collected and immediately processed. Three
healthy adults (donors E, K and V) with no prior exposure to
Plasmodium parasites were used in this study. Samples were
collected into 9 ml ammonium heparin tubes (16I.U. heparin/
ml blood; S. Monovette) and diluted 1:1 with RPMI 1640 (Sigma
Aldrich). Peripheral blood mononuclear cells (PBMCs) were
isolated by density gradient centrifugation with Ficoll Paque TM
plus (GE Healthcare). The cells were washed twice with 2% FBS
in RPMI 1640; resuspended in culture medium (RPMI 1640)
containing 5% autologous serum, 1% 1006PenStrep (Invitrogen)
and 2 mM L-Glutamine (Invitrogen); transferred to 24-well flat-
bottomed plates (Nunc); and cultured as described below.
PBMC/parasite co-incubation
Freshly isolated mononuclear cells from donors E and K were
incubated under four different conditions: in culture medium
alone (CM or untreated); with a mixture of IL-12 and IL-18
(Peprotech and MBL, respectively; 200 ng/10
6 cells each); or with
schizont-iRBCs or with uninfected erythrocytes (uRBCs) at a ratio
of three RBCs for each mononuclear cell. PBMCs from donor V
were incubated under two different conditions: with iRBCs and
with culture medium. Co-cultures were maintained at 37uC and
5% CO2 for 24 hours. After the incubation, NK cells were
isolated from PBMCs, checked for purity by FACS, and subjected
to RNA extraction as described below. The experiment was
repeated three times (1–3 weeks apart) for each one of the three
donors.
To evaluate the activation pattern of each donor’s NK cells,
PBMCs were likewise incubated with schizont-iRBCs (1 PBMC : 3
iRBC), with iRBCs together with human IFN-alpha2b (Myltenyi
Biotec; 500 U/10
6 cells), or with a mixture of IL-12 and IL-18
(200 ng/10
6 cells each) and also kept in culture medium alone.
After 24 hours at 37uC and 5% CO2, cells were harvested, iRBCs
were lysed and PBMCs were stained for flow cytometry.
Cell surface and intracellular staining for flow cytometry
The following antibodies were used for flow cytometric staining:
CD56-FITC, CD3-PE, CD3-APC, CD69-PE, intracellular IFN-c-
PE, 7AAD and the appropriate isotype controls (all from BD
biosciences). Extracellular staining of cells was performed
according to the manufacturer’s instructions. For intracellular
staining of IFN-c, Brefeldin A solution (Biolegend) was added
4 hours before the end of the incubation period and cells were
fixed and permeabilized with Cytofix/Cytoperm Fixation/Per-
meabilization Kit (BD Biosciences) according to the manual
instructions.
Isolation of NK cells
After 24 hours of co-incubation, cells were harvested, separately
treated with BD Pharm Lyse lysing buffer (BD) for RBC rupture,
and washed twice with auto-MACS Rinsing Solution (Miltenyi
Biotec). NK cells were enriched from PBMCs by negative selection
with the NK Cell isolation Kit (Miltenyi Biotec) according to the
manufacturer’s instructions. NK cells were counted and tested for
viability with trypan blue, and purity was determined by flow
cytometry. A purity of $93% CD56
+CD3
2 cells was considered
acceptable (Figure S1).
RNA extraction and Microarrays
Total cellular RNA was isolated from the enriched NK cells
with RNeasy Mini Kit (Qiagen, Hilden, Germany). The quality of
each specimen was checked using an Agilent BioAnalyzer 2100
(Agilent, Germany). RNA was processed for Affymetrix Gene
Chips using the Affymetrix Whole Transcript Sense Target
Labeling Kit (Affymetrix, Santa Clara, USA). Fragmented and
labeled cDNA were hybridized onto human HuGene1.0 ST Gene
Chips (Affymetrix). The staining of biotinylated cDNA and
scanning of arrays were performed according to the manufactur-
er’s recommendations. The complete microarray data is deposited
at the Gene Expression Omnibus (GEO) of the National Center
for Biotechnology Information (NCBI) under the series number
GSE24791. Validation of the method was performed by RT-PCR.
Rea- time PCR
cDNA was synthesized from total RNA using the Quantitec
Reverse Transcription kit (Qiagen) with the elimination of
Genomic DNA according to the manufacturer’s instructions.
Amplification of IFIT1, IFIT3 and IFI44L genes was carried out
in duplicates using the Rotor Gene Syber Green PCR Kit
(Qiagen) with Quantitec Primer Assay (both from Qiagen).
Cycling conditions for fast two-step RT-PCR on Rotor-Gene
cycles were applied according to the Primer Assay Handbook
(Qiagen). Levels of target mRNA expression were determined
using the 2
2DDCT method with GAPDH as the endogenous
reference gene and the CM samples as calibrators.
NK cells expansion and co-culture with parasites for
growth inhibition assay
PBMCs and NK cells from donor E were respectively purified
and isolated as described above. NK cells ($93% CD56
+CD3
2)
were cultured in IMDM medium (Sigma) with 5% autologous
serum, 200 U/ml IL-2 (Peprotech) and irradiated JY cells at a
1:3–3:1 ratio (NK:JY). Purified NK cells expanded for 2–4 weeks
(eNK) were co-incubated at 37uC with ring stage 3D7-iRBCs in
parasite growth medium at a 1:3 or 5:1 ratio (NK:3D7) in parasite
atmosphere. Additionally, IFN-alpha2b (500 U/10
6 cells) or a
mixture of IL-12 and IL-18 (200 ng/10
6 cells each) were added to
the system. Parasites were cultured alone as a control and the
initial parasitemia was set as 0,05% in 1,5% hematocrit. After 24 h
and 48 h of incubation, culture samples were frozen at 220uC,
then thawed and inhibition of parasite growth was quantified by a
Transcriptome of NK Cells
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described elsewhere [13].
Bioinformatic analysis
Raw CEL-files were imported into Expression Console 1.0
(Affymetrix, Santa Clara). RMA16 was used for array normaliza-
tion and signal calculation. Normalized signal values were
imported into Genespring 11 (Agilent Technologies). Significance
was calculated using a t-test without multiple testing correction,
selecting all the transcripts with a minimum change in expression
level of 1.5-fold together with a p-value of ,0.05. Subsequently,
transcripts in common for all donors in each treatment were
compiled and gene network analysis and functional categorization
was performed with Ingenuity Pathway Analysis (IPA) (www.
ingenuity.com). The p-value associated with a biological process or
pathway annotation for IPA is a measure of its statistical
significance with respect to the Functions/Pathways/Lists Eligible
molecules for the dataset and a reference set of molecules (which
define the molecules that could possibly have been Functions/
Pathways/Lists Eligible). The p-value is calculated with the right-
tailed Fisher’s Exact Test. The ratio is calculated by taking the
number of genes from the dataset that participate in a Canonical
Pathway, and dividing it by the total number of genes in that
Canonical Pathway. The ratio indicates the percentage of genes in
a pathway that were also found in the uploaded gene list (or the
Functions/Pathways/Lists Eligible genes if a cut off was specified)
and is therefore useful for determining which pathways overlap
with most of the genes in the dataset.
Results
P. falciparum-iRBCs induce the up-regulation of type I
interferon-related genes in NK cells
Affymetrix microarrays were used to evaluate the gene
expression profile of NK cells isolated from PBMCs (purity
$93%; Figure S1) that were incubated with iRBCs to detect the
changes that Plasmodium-iRBCs impose on the gene repertoire of
NK cells. The analysis showed that 192 genes were commonly
modulated for all donors in response to iRBCs contact. Of those
genes, nine were down-regulated and 183 were up-regulated in
comparison to untreated cells (Table S1). The expression profile
was characterized by the induction/suppression of genes mainly
related to immune response and response to virus (IFIT1, IFIT3,
OAS3, KLRG1), chemotaxis (CXCL10, CCR1, CCL4L1), signal
transduction (CD38, IFITM1, FAS), regulation of transcription
(STAT2, IRF7 STAT3), intracellular signaling pathway (JAK,
RASGRP3, RASGRP2), and NK cytotoxicity (SLAMF7), among
others. A summary of the most highly up- and down-regulated
genes is depicted in Table 1. A portion of the most highly up-
regulated genes (fold change $10) encode proteins mostly related
to interferon signaling (IFIT1, IFIT3, IFI44L, IFIT2, IFI6, and
IFI44), especially via IFN-a. The most highly down-regulated
genes (fold change #21.5) are mainly involved in chromatin
assembly, receptor activity in the immune response and signal
transduction. Three representative genes were chosen for micro-
array validation by RT-PCR (Figure 1).
Top Networks and Pathways related to iRBCs-induced
genes
Ingenuity Systems generated top networks, with a score higher
than 40, based on the analysis of the iRBCs-regulated NK genes.
Antimicrobial/Inflammatory Responses and Infection Mechanism are the
main functions associated with the top-scoring networks (Table 2
and Table S2). Moreover, Interferon signaling (p=2,17E-14) and
Activation of IRF by cytosolic pattern recognition receptors (p=2,9E-09) were
identified as the top canonical pathways linked to the modulated
genes (Figure 2A and Table S3). The highest strength of association
was found with the Interferon Signaling canonical pathway. Eleven of
the 30 molecules that compose the pathway were regulated on NK
cellsbyco-culture with parasites(ratio:0.367). Thepathway and the
modulated genes are depicted in Figure 3.
Table 1. Top up/down-regulated genes on NK cells due to
co-culture with P.falciparum-iRBCs.
Symbol Aff. ID FC Location Type
IFIT1 7929065 34,50 Cytoplasm other
RSAD2 8040080 21,55 unknown enzyme
IFIT3 7929052 19,71 Cytoplasm other
OAS3 7958895 15,48 Cytoplasm enzyme
MX1 8068713 15,42 Nucleus enzyme
IFI44L 7902541 15,33 unknown other
IFIT2 7929047 12,47 unknown other
IFI6 7914127 12,10 Cytoplasm other
OAS1 7958884 11,60 Cytoplasm enzyme
IFI44 7902553 11,32 Cytoplasm other
MX2 8068697 11,00 Nucleus enzyme
CBX7 8076185 21,79 Nucleus other
KLRG1 7953835 21,83 Plasma MB other
RASGRP2 7949104 21,91 Cytoplasm other
SYNE1 8130211 21,92 Nucleus other
HERC1 7989516 21,96 Cytoplasm other
CMKLR1 7966089 22,03 Plasma MB GPCR
AHNAK 7948667 22,27 Nucleus other
FGR 7914112 22,49 Nucleus kinase
PTGDR 7974363 22,58 Plasma MB GPCR
iRBCs-infected erythrocytes; Aff. ID-affymetrix identification; FC-fold change;
MB-membrane; GPCR-G protein coupled receptor.
doi:10.1371/journal.pone.0024963.t001
Figure 1. Validation of the microarray results by RT-PCR. Three
representative iRBCs-induced NK genes are depicted. Values represent
the mean of the relative fold change obtained for each replicate per
donor. Levels of target mRNA expression were determined using the
2
2DDCT method with GAPDH as the endogenous reference gene and
the untreated samples (CM) as calibrators.
doi:10.1371/journal.pone.0024963.g001
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IL-12 and IL-18
To compare patterns of NK cell activation, PBMCs were also
treated with IL-12 and IL-18, well-described NK cell stimulators.
Treatment with the cytokine mix resulted in the regulation of 576
NK genes in both donors E and K. Down-regulated genes totalled
160, whereas 416 genes were up-regulated (Table S4). Modulated
genes included those related to the immune response (IFN-c,
CD25), signal transduction (P2RX5, MT2A, KLRF1), complement
activation (CD55), antigen presentation (CD83), chemotaxis (CCR4,
CXCL10, CX3CR1), DNA replication/repair (CHEK1, TYMS),
transcription (IRF8, MYC), and cytokines (IL26, IL6), among
others. The most up and down-regulated genes share similar
molecular as well as biological functions such as receptor activity
and signal transduction/immune response, respectively (Table 3;
fold change $12 and fold change #25.5).
Top Networks and Pathways related to IL-12 and IL-18-
induced genes
The highest score upon analysis of the IL-12 and IL-18
modulated genes was given to the network that listed Gene
Expression, Infection Mechanism, RNA Post-Transcriptional Modification as
associated functions (score: 50; Table 2 and Table S5). The most
significant canonical pathways obtained from Ingenuity analysis
were TREM1 Signaling (p=2,69E-07) and the Protein Ubiquitination
Pathway (p=3,38E-07; Table S6). The former canonical pathway
is composed of 69 molecules and 13 out of those were found to be
modulated in NK cells, resulting in a high strength of association
(ratio: 0,188; Figure 2B). The top canonical pathway and its
modulated genes are depicted in Figure S2.
Gene expression similarities between iRBCs- and IL mix-
treated NK cells
There were about 400 additional transcripts regulated by IL-12
and IL-18 in comparison to iRBCs-induced genes. In total, only
40 were modulated by both treatments. Among those are
transmembrane receptors (IL2RA, CCR1, IL12RB2), cytokines
(CXCL10, CCL3), transcription regulators (STAT3, LBA1) and
enzymes (PTPN2, HSPA8).
For a general overview, members of the Interferon signaling
pathway, TREM-1 signaling pathway and other genes that play a role
in immune response were arranged in a heatmap (Figure 4). The
image depicts the comparison of the gene fold change between the
three different donors in response to the treatment type. It is clear
that, although the same pattern of gene regulation is generally
maintained among the donors within the different treatments,
parasites and IL-12/IL-18 affect the transcription of NK genes in
a different manner.
Influence of uninfected erythrocytes on NK cells
Since the RBCs and the NK cells used in this study are from
different donors, PBMCs from donor E and K were incubated
with uRBCs in order to control the allogeneic responses that might
affect gene expression in NK cells. This analysis showed that in
total only nine genes were modulated due to uRBCs treatment.
NK cells from donor E up-regulated six genes, whereas donor K
cells showed up-regulation of three different genes. The biological
processes or molecular functions of some of these genes have not
been described (RNU5E, SNORD47), and others are known to play
a role in RNA splicing (SNRPN) and translation (EEF1A1).
Patterns of NK activation and inhibition of parasite
growth by expanded NK cells
The activation characteristics of NK cells from the three donors
studied were next examined. NK cell up-regulation of the CD69
membrane surface protein and production of IFN-c were
examined in response to incubation with iRBCs, iRBCs plus
IFN-a, IL-12 and IL-18, and culture medium alone. All the
donors’ NK cells up-regulated CD69 due to iRBCs incubation,
although the strength of the responses differed among donors
(Figure 5A). In response to parasite stimulation, only 10.7% of the
NK cells from donor K up-regulated CD69, while 16.9% and
39.5%, respectively, of the NK cells from donors V and E
responded. The addition of IFN-a to the system contributed to
NK activation by increasing the percentage of cells that up-
regulated CD69 for all donors. IL-12/IL-18 treatment induced
around 80% of the donors’ cells to express CD69. None of the co-
culture conditions induced IFN-c release by NK cells to a large
extent, except for the IL-12/IL-18 treatment (Figure 5B).
To further examine the cytotoxic characteristics of the cells used
in the study, we co-cultured expanded NK cells (eNK) from donor
E with 3D7-iRBCs. Neither the 24 h/48 h co-culture time nor the
different 3D7:eNK ratios (1:5; 3:1) appeared to have a significant
Table 2. Top networks and functions associated with 3D7- or IL-12/IL-18-induced transcripts on NK cells.
NW ID Network functions related to 3D7-induced transcripts Score
1 Antimicrobial Response, Inflammatory Response, Infection Mechanism 61
2 Antimicrobial Response, Inflammatory Response, Infection Mechanism 54
3 Infection Mechanism, Organismal Injury and Abnormalities, RNA Damage and Repair 44
4 Infection Mechanism, Antimicrobial Response, Inflammatory Response 40
5 Post-Translational Modification, Protein Folding, Cell Morphology 31
NW ID Network functions related to IL-12/IL-18-induced transcripts Score
1 Gene Expression, Infection Mechanism, RNA Post-Transcriptional Modification 50
2 Cell Death, Post-Translational Modification, Protein Folding 43
3 DNA Replication, Recombination, and Repair, Cellular Growth and Proliferation 40
4 Cell Death, Genetic Disorder, Immunological Disease 37
5 Cell Morphology, Hematological System Development and Function, Cancer 36
NW ID-network identification; IL-interleukin.
doi:10.1371/journal.pone.0024963.t002
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affected by the addition of IFN-a and IL-12/IL-18 to the system
(Figure 6).
Discussion
The objective of this study was to observe the transcriptional
changes that malaria parasites impose on NK cells in order to gain
a deeper knowledge of the mechanisms behind such interaction.
An in vitro approach was used to investigate the specific immune
response to malaria. Such an approach is widely used in research
especially in diseases where primary material is difficult to access.
The gene expression profile and activation characteristics of NK
cells incubated with iRBCs at a 1:3 ratio (PBMCs:iRBCs) were
examined at one time point (24 h) after co-culture. These
conditions were chosen based on prior observations showing that
optimal NK cell IFN-c production occurs at either 1610
6 or
1610
7 iRBCs per 10
6 PBMCs and that the peak of IFN-c release
occurs between 15 and 24 hours after stimulation [3].
First, these results demonstrate that all donors’ NK cells have a
very similar pattern of gene regulation for each different
treatment. An interferon signaling gene expression signature is
Figure 2. Top canonical pathways associated with 3D7- and IL-12/IL-18-induced NK cell genes. Canonical pathways were obtained using
the Ingenuity System upon analysis of the genes differentially modified in NK cells. Top canonical pathways are indicated by the grey bars on the x-
axis. The association of the data set with the given pathway is depicted in the y-axes and was determined based on the p-value and on the ratio
(strength of the association - black line). The threshold (dashed black line) is shown at p,0.05. A. 3D7-induced: IS: Interferon Signaling; IRF:
Activation of Interferon Regulatory Factor family of transcription factors by Cytosolic Pattern Recognition Receptors; PRR: Role of Pattern Recognition
Receptors in Recognition of Bacteria and Viruses; PMS: Pathogenesis of Multiple Sclerosis; RMAS: Retinoic acid Mediated Apoptosis Signaling; RIG1-LR:
Role of Retinoic Acid Inducible gene 1-like receptors in Antiviral Innate Immunity; DNK: Crosstalk between Dendritic Cells and Natural Killer Cells. B.
IL-12+IL-18-induced: TREM1: Triggering Receptor Expressed in Myeloid Cell 1 Signaling; PUP: Protein Ubiquitination Pathway; OCP: One carbon
Pool by Folate; CMLS: Chronic Myeloid Leukemia Signaling; SCLCS: Small Cell Lung Cancer Signaling; A-tRNA: Aminoacyl-tRNA Biosynthesis; TCD: T
Helper Cell Differentiation.
doi:10.1371/journal.pone.0024963.g002
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inflammatory response, mainly mediated by type I interferon were
modulated. A recent microarray study has described the up-
regulation of IFIT1, IFIT3, and CXCL10 (after 1 h of activation)
and IFI44, IFIT2, and ISG20 (after 18 h of activation) in IFN-a-
treated whole PBMCs from healthy donors. Arrays performed
with isolated cell subsets (NK cells, monocytes and T cells) showed
the up-regulation of OAS2, OASL, ISG20 and IFI44 [14]. Another
group has reported the up-regulation of TNFSF10 (TRAIL), IFIT
and OAS genes in NK cells isolated from IFN-a-2b-stimulated
PBMCs from five healthy donors [15]. The expression profile of
IFN-a-treated cells in these studies was very similar to the profile
detected in iRBCs-activated NK cells in the current study, which
did not utilize IFN-a. Therefore, such similarities provide support
of a clear iRBCs-induced type I interferon-related response in NK
cells. Moreover, the regulated molecules were linked to top
canonical pathways, all belonging to the ‘‘cellular immune
response’’ category. Some of the regulated genes were not yet
assigned to a clear role in this category, but most genes were linked
to well-known biological functions, mainly in infection control and
inflammation. As in systemic lupus erythematosus (LE) [16,17],
such inflammatory components were recently detected as
increased IFN-a/b-inducible genes in the blood of patients with
Tuberculosis (TB), especially in their purified neutrophils [18]. Its
correlation with disease severity provided primary data supporting
a role for type I IFN in the pathogenesis of human disease. Here,
we have observed that mostly the same transcripts found in the
mentioned studies were overexpressed in our NK cells due to
parasite co-incubation. It is difficult to extrapolate the LE/TB
findings to malaria without confirmation with longitudinal studies;
however, it is possible that the role of type I interferon signaling in
diseases caused by intracellular pathogens will be a marker of
disease progression and immune response development.
In this study, the IFIT family was found to be among the most
highly up-regulated NK genes induced by parasites. To date, little
is known about their function. Most of the evidence characterizes
these proteins as inhibitors of cellular and viral processes such as
protein translation [19]. Recent findings indicate that IFIT
proteins are substantially induced during infection possibly
reflecting a functional role. A complex formed by IFIT1, 2 and
3 was observed to exert antiviral activity by physically engaging
microbial triphosphorylated-RNA suggesting that these proteins
possibly have the ability to bind to various types of nucleic acids of
other diverse microbes [20]. Plasmodium DNA, therefore, could be
one target. In fact, DNA sensing and its relation to type I
interferons have recently been revealed to be important in innate
immunity to malaria [21]. Plasmodium genomic DNA, rich in AT
motifs, was shown to generate type I interferon through two
suggested innate pathways (a TLR9- and a STING- driven) which
converge on the IRFs to regulate IFN gene transcription.
Interferon type I, in turn, could possibly influence the outcome
of the disease.
Instead of IFN-a/b-related genes though, we expected to
observe a direct up-regulation of the IFN-c gene in all donors
treated with iRBCs (as was detected with the IL-12/IL-18 treated
NK cells). To our surprise, NK cells from only one donor (donor
Figure 3. Type I interferon transcripts are induced by parasites on NK cells. Ingenuity Pathways Analysis identified the canonical pathway
‘‘Interferon Signaling’’ as highly associated with the 3D7-regulated genes on NK cells. Mainly IFN-ab transcripts are induced. The differentially-
regulated genes are marked in red (up-regulation) or green (down-regulation).
doi:10.1371/journal.pone.0024963.g003
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lower than that induced by IL-12 and IL-18. Nevertheless, it is
very likely that this 3D7-mediated induction of type I-related genes
reflects the first steps of a cascade of events leading to IFN-c
release. In the case of a viral infection, there is consensus that the
activation of NK cells is critically dependent on type I IFN
signaling in vivo and that this activation is achieved by its direct
action on NK cells [22]. Others have shown that type I IFNs are
an early and critical regulator of NK cell number, activation and
antitumor activity and that, in combination with IL-18, type I IFN
plays an important role in inducing IFN-c production by NK cells
[23,24]. In addition to overlapping with type II interferon at
multiple levels of the JAK/STAT signaling pathway, type I
interferons have unique regulatory mechanisms for both their own
signaling as well as IFN-c signaling [25]. A very recent report
showing the responses of human PBMCs to stimulation with type I
and II interferons, among other cytokines, is in agreement with
this co-induction concept. The authors describe the responses to
IFN-c as being restricted to a subset of type I interferon-inducible
genes whereas responses to type I interferon were highly
stereotyped and resulted in the up-regulation of genes such as
OAS1-3, MX1/2, CXCL10, STAT1/2, IRF2/7 and IFIT1-5.
However, after four hours of IFN-a treatment, transcripts of type
II interferon itself were induced, which the authors suggested
might play a role in the initiation of an IFN-c-dependent
transcriptional programs in type I IFN-treated cells [26]. Along
these lines, L. major-induced IFN-a/b was suggested to mediate key
events of the innate response to the parasite. NK cell cytotoxicity
and IFN-c secretion early in infection were shown to be decreased
in the event of type I interferon blockage in mice [27]. In a recent
study with L. mexicana infection, type I interferon was also
described to promote the early IFN-c and IL10 expression [28].
P. falciparum-mediated IFN-a responses have been previously
reported by few in vivo and in vitro studies [29–31]. In accordance
with our findings, new microarray evidence show that expression
profiling of PBMCs derived from patients with P. falciparum
malaria show elevated expression of interferon-inducible genes
(ISGs) [21]. The study further confirms that PBMCs stimulated
with iRBCs induce IFN-a at the protein level and IFN-b mRNA,
suggesting a possible role for type I interferons in malaria.
Although their gene expression profiling was performed with a
mixed group of cells and hence cannot be traced to one specific
cell population, the NK cells in the present study appear to
respond in concert with PBMCs from malaria-infected individuals
in that previous study. Furthermore, human plasmatocytoid
Table 3. Top up/down-regulated genes on NK cells due to
treatment with IL-12 and IL-18.
Symbol Aff. ID FC Location Type(s)
IFNG 7964787 92,46 Extr. Space cytokine
IL2RA 7931914 37,33 Plasma MB Tmb R
MIR155HG 8068022 34,30 unknown other
SLC27A2 7983650 20,71 Cytoplasm transporter
DPP4 8056222 17,57 Plasma MB peptidase
CD274 8154233 16,19 Plasma MB other
CDC6 8007071 14,25 Nucleus other
MYO1B 8047127 13,25 Cytoplasm other
P2RX5 8011415 13,10 Plasma MB ion channel
TNFSF4 7922343 13,05 Extr. Space cytokine
PTGDR 7974363 25,54 Plasma MB GPCR
YPEL1 8074780 25,56 Nucleus enzyme
FGFBP2 8099471 25,63 Extr. Space other
PIK3IP1 8075483 25,78 unknown other
KLHL24 8084219 25,79 unknown other
AHNAK 7948667 25,96 Nucleus other
CX3CR1 8086344 26,68 Plasma MB GPCR
FAIM3 7923917 27,37 unknown other
SH2D1B 7921900 27,56 unknown other
KLRF1 7953892 210,20 Plasma MB Tmb R
IL7R 8104901 211,12 Plasma MB Tmb R
IL-interleukin; Aff. ID-affymetrix identification; FC-fold change; MB-membrane;
Extr.-extracellular; Tmb R-transmembrane receptor; GPCR-G protein coupled
receptor.
doi:10.1371/journal.pone.0024963.t003
Figure 4. Comparison of the gene expression patterns between
donors and treatments. Members of the Interferon signaling
pathway, the TREM-1 signaling pathway, and other genes that play a
role in the immune response were selected. The image depicts the log
of the fold change of NK genes regulated due to co-culture with 3D7-
infected erythrocytes (iRBCs) or with the cytokines IL-12 andIL-18. The
expression profile is shown for the three different donors (E, K, and V).
doi:10.1371/journal.pone.0024963.g004
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response to P. falciparum-schizonts, which in turn promote cd T
cell proliferation and IFN-c production [32]. Microarray analysis
of whole-blood cells from P. chabaudi-infected mice [33] demon-
strated that the predominant responses at about 16 h to 24 h post-
infection were dominated by interferon-induced genes and that
after 32 hours there was a dramatic change in the regulated
transcripts. However, there are contradictory studies regarding the
importance of IFN-a in the immune response against malaria. A
recent study has described that neither pDCs nor IFN-a/b were
essential for parasite clearance as mice depleted of pDCs or IFN-
a/b receptor knock-out mice could control P. chabaudi infection
[34]. In contrast, experimental evidence suggested that IFN-a
treatment of P. berghei-infected mice has a protective effect on the
evolution of cerebral malaria and inhibits the development of P.
yoelli blood-stage infections in mice [35,36]. In addition,
polymorphisms in the IFN-a receptor 1 were associated with
protection against cerebral malaria in humans [37]. High titers of
antiviral activity have been reported to be due to IFN-a, and a
positive correlation between degree of parasitemia, interferon
titers and NK cell activity was observed in acutely ill P. falciparum-
infected children [29]. IFN-a, in combination with iRBCs, boosted
the up-regulation of CD69 on NK cells but did not up-regulate
IFN-c in the present study. Additionally, when testing the
cytotoxicity of expanded NK cells from Donor E against
Plasmodium, no significant interference in parasite growth was
observed, even with the addition of IFN-a. Such lack of
cytotoxicity was likely due to donor-related characteristics (low
IFN-c responder) but it will be important to determine the reason
that expanded NK cells treated with IL-12/IL-18 (which lead to
IFN-c release) did not inhibit parasite growth. As mentioned
before, others have described that the peak of IFN-c induction
occurs around 15–24 h after co-culture with parasites and that this
response is dependent on cross-talk with other cells. Thus, it would
be worth observing whether HPR2 is suppressed at earlier time
points than 24 h and 48 h after co-culture and whether the
addition of accessory cells to the system would interfere with
parasite growth. To further investigate the importance of IFN-a
on the NK response against parasites, 3D7-iRBCs were co-
cultured with NK92 (NK cell line) in which IRF9, STAT1 or
STAT2 were knocked down by siRNA and RT-PCR was used to
verify the suppression of EBA-175 and BAEBL/EBA-140, which
are vital parasite genes involved in invasion (our unpublished
observations). However, no differences were observed in cytotox-
icity of the siRNA -transfected cells against 3D7. One potential
explanation for this is the fact that, due to the difficulties in
obtaining large amounts of fresh NK cells, these experiments were
performed with an NK cell line, which might not reflect
physiological conditions. Another reason could be the choice to
evaluate cytotoxicity by the NK population, although there is still
considerable debate regarding the importance of NK and T cells
in immunity to malaria. A very recent study with P. chaubadi-
infected mice shows that the suppression of infection is dependent
on cd T cells and independent of NK cells [38]. Conversely, a
study with a large cohort of malaria-naive donors shows that the
majority of IFN-c
+ T cells are ab and not cd T cells. Moreover,
the authors of that study observed that NK cells dominate the
early IFN-c response (around 18 h), that NK and T cells
contribute equally to the response at 24 h, and that T cells
dominate from there-after [39].
The combination of IL-12 and IL-18 augments NK cell activity
and stimulates NK production of IFN-c, a cytokine suggested to
control P. falciparum infection [3–5]. PBMCs stimulation with high
doses of IL-12 and IL-18 (as performed in this study) was
previously shown to up-regulate NK cell expression of CD69 and
CD25, and to stimulate the release of IFN-c [5]. We were
interested in determining whether there were similarities between
the transcripts induced by IL-12/IL-18 and iRBCs. However, this
was not the case. IL-12/IL-18 treatment induced genes strongly
correlated to the signaling pathway triggered by TREM 1,a n
immune regulatory molecule that plays a role in innate and
adaptive immune response [40]. The molecule is expressed on
monocytes/macrophages, dendritic cells, NK cells, and neutro-
phils [41,42] and its activation triggers molecules involved in cell-
to-cell signaling/interactions and inflammatory responses (includ-
ing CD83, IL-6 and TNF among others). NK cells induced by
iRBCs in our study also modulated some genes related to this
pathway although not as strongly as the IL-12/IL-18 treatment.
The second strongest gene association was found with the protein
ubiquitination pathway, which consists of a concerted action of
enzymes indispensable for the rapid removal of proteins, the
regulation of gene transcription, translational quality control and
immune surveillance, to mention some of the functions. A
prominent molecule in immune surveillance is IFN-c, which was
found to be the top molecule (FC=92,460) up-regulated by IL-
12/IL-18 treatment in this study. The ubiquitin-proteasome
system is essential for antigen presentation on MHC class I
Figure 5. Regulation of CD69 and IFN-c on NK cells. PBMCs from the three donors were incubated with 3D7 schizont-infected erythrocytes
(iRBCs), with iRBCs plus human IFN-a or with a mixture of IL-12 and IL-18, or were leftuntreated in culture medium (CM) for 24 hours and analyzed by
flow cytometry. The gating strategy for NK cells (CD56
+CD3
2 lymphocytes) and the percentages of CD69
+ (A) and IFN-c
+ (B) cells for each treatment
are depicted. Upper rows: donor V; middle rows: donor E; lower rows: donor K.
doi:10.1371/journal.pone.0024963.g005
Figure 6. The influence of expanded NK cells and IFN-a on
parasite growth. Expanded NK cells (eNK) from donor E were co-
cultured with 3D7 ring-infected erythrocytes (iRBCs), with iRBCs plus
human IFN-a, or with a mixture of IL-12 and IL-18. Parasites were
incubated alone as a control. After 24 h and 48 h, culture samples were
frozen at 220uC, thawed and inhibition of parasite growth was tested
by HRP2 ELISA assay. Values represent the mean of three different
experiments. Ratios are depicted as 3D7:eNK (1:3 and 5:1).
doi:10.1371/journal.pone.0024963.g006
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induces immune cells to express immunoproteasomes that impose
changes on the normal cascade of actions of the pathway,
consequently leading to the stimulation of host defence [43].
Overall, this study provides evidence that P. falciparum parasites
induce IFN-a-associated transcripts in human NK cells within the
first 24 hours of interaction. This study also demonstrated that the
NK transcriptional changes induced by IL-12 and IL-18 are
diverse from those induced by 3D7. Whether both patterns of
expression converge at one stage and whether IFN-a-related
transcripts result in IFN-c signaling, should be further investigated
by microarrays and functional studies at different time points. The
role of IFN-a in malaria is still controversial and understudied.
This study suggests inherent regulatory molecules of the NK
response to parasites that might be potential targets to be
considered in malaria vaccine development.
Supporting Information
Figure S1 Purity of the isolated NK cells measured by
FACS. Values represent the percentage of pure NK cells
(CD56
+CD3
2) before and after isolation within the four different
co-culture conditions: CM: culture medium only; iRBCs: +infect-
ed erythrocytes; uRBCs: +uninfected erythrocytes; IL-12+IL-18:
IL-12 and IL-18. E1, E2 and E3 represent the three replicates for
donor E; K1, K2 and K3 represent the three replicates for donor
K and V1, V2 and V3 represent the three replicates for donor V.
(TIF)
Figure S2 IL-12/IL-18 treatment of NK cells induces
transcripts related to the TREM-1 signaling pathway.
The ‘‘Triggering receptor expressed in myeloid cell 1’’ (TREM-1)
signaling pathway was identified by the Ingenuity Pathways
knowledge base as highly associated with the IL-12/IL-18-
regulated genes on NK cells. Up-regulated genes are highlighted
in red and the down-regulated genes are highlighted in green.
(TIF)
Table S1 Complete list of P. falciparum-iRBCs induced
genes.
(XLS)
Table S2 Complete list of Networks related to P.
falciparum-iRBCs induced genes.
(XLS)
Table S3 Complete list of Canonical Pathways related
to P. falciparum-iRBCs induced genes.
(XLS)
Table S4 Complete list of IL-12/IL-18-induced genes.
(XLS)
Table S5 Complete list of Networks related to IL-12/IL-
18-induced genes.
(XLS)
Table S6 Complete list of Canonical Pathways related
to IL-12/IL-18-induced genes.
(XLS)
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